Atlas Trials

Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia

Clinical trial NCT05611593 · UNKNOWN

Trial details

NCT number
NCT05611593
Sponsor
Follicle Pharma Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Androgenic Alopecia
Start date
2022-10-20
Primary completion
2024-12-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.